Quantifying the effects of renal impairment on plasma concentrations of the neuroendocrine neoplasia biomarkers chromogranin A, chromogranin B, and cocaineand amphetamine-regulated transcript

Clinical Chemistry

Volumn 58, Issue 5, 2012, Pages 941-943

  Bech, Paul R ^a   Ramachandran, Radha ^a,b,c   Dhillo, Waljit S ^a,b   Martin, Niamh M ^a,b   Bloom, Stephen R ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Endocrine Unit and   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A; CHROMOGRANIN B; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE;

ADULT; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; LETTER; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PLASMA; RADIOIMMUNOASSAY; TUMOR DIAGNOSIS;

CASE-CONTROL STUDIES; CHROMOGRANIN A; CHROMOGRANIN B; GLOMERULAR FILTRATION RATE; HUMANS; NERVE TISSUE PROTEINS; NEUROENDOCRINE TUMORS; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84860652873     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.176099     Document Type: Letter

References (5)

1. Schimmack S, Svejda B, Lawrence B, Kidd M, Modlin IM. The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbecks Arch Surg 2011;396:273-98.
2. Lawrence B, Gustafsson BI, Kidd M, Pavel M, Svejda B, Modlin IM. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 2011;40:111-34, viii.
3. Stridsberg M, Eriksson B, Fellstrom B, Kristiansson G, Tiensuu JE. Measurements of chromogranin B can serve as a complement to chromogranin A. Regul Pept 2007;139: 80-3. (Pubitemid 46216481)
4. Bech P, Winstanley V, Murphy KG, Sam AH, Meeran K, Ghatei MA, Bloom SR. Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy. J Clin Endocrinol Metab 2008;93:1246-53. (Pubitemid 351519717)
5. Anothaisintawee T, Rattanasiri S, Ingsathit A, Attia J, Thakkinstian A. Prevalence of chronic kidney disease: a systematic review and metaanalysis. Clin Nephrol 2009;71:244-54.